Aurobindo Pharma USA Inc, a wholly owned subsidiary of $AUROPHARMA has secured US FTC approval to acquire 100% membership interest in Lannett Company LLC. The transaction, agreed with LANNETT SELLER HOLDCO, INC., is now expected to close this month, ahead of the earlier June 2026 timeline, with the company committed to updating stock exchanges on further developments. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.